Skip to main content
. 2021 Feb 21;24(5):615–624. doi: 10.1016/j.jval.2020.12.009

Table 1.

Summary of key input data.

Data Base case value Source
1. COVID-19 epidemic in China
 1.1 Total number of COVID-19 cases 83 650 (95% CI, 73 510-97 330) [13]
 1.2 Total COVID-19 deaths 3345 (95% CI, 3007-3905) [13]
2. Direct costs
 2.1 Direct healthcare cost
 2.1.1 Proportion of mild/moderate, severe, and critical case (%) 81.5%; 13.8%; 4.7% [36]
 2.1.2 Length of hospital stay for patients with mild/moderate, severe, and critical COVID-19 (day) 14; 21; 42 [37]
 2.1.3 Average cost for close contact diagnosed as COVID-19 negative (RMB) 532 [7]
Data Base case value Source
 2.1.4 Average cost for suspected cases diagnosed as COVID-19 negative (RMB) 1002 [7]
 2.1.5  Average cost for confirmed case - nonsevere, severe, critical (RMB) 5601; 52 951; 151 344 [7]
 2.2 Direct non-healthcare cost
 2.2.1 Weighted quarantine cost for suspected cases diagnosed as COVID-19 negative (RMB) 1170 [7]
 2.2.2 Weighted quarantine cost for suspected cases diagnosed as COVID-19 positive (RMB) 481 [7]
 2.2.3 Weighted quarantine cost for all suspected cases (RMB) 757 [7]
Categories of data Data value Source
 2.3 Total cost on risk allowance for medical staff (100 million RMB)
 2.3.1 Number of front-line healthcare staff 42 600 [36]
 2.3.2 Daily allowance (RMB) 300 [38]
3. Indirect costs
 3.1 Productivity loss
 3.1.1 National average salary per working day (RMB) 272 [15]
 3.1.2 Working time lost - people not considered to have had COVID-19 (day) 23 [7]
 3.1.3 Working time lost - close contact (day) 28 [7]
 3.1.4 Working time lost - suspected case (day) 24 [7]
Categories of data Data value Source
 3.1.5 Working time lost - confirmed case - nonsevere, severe, critical, dead (day) 37; 41; 42; 44 [7]
 3.2 National return to work index
 3.2.1 March 3, 2020(%) 57.42 [22]
 3.2.2 March 10, 2020(%) 64.15 [22]
 3.2.3 March 17, 2020(%) 69.95 [22]
 3.2.4 March 24, 2020(%) 74.82 [22]
4. DALY
 4.1 Disability weight of mild/moderate COVID-19 0.01 [20]
 4.2 Duration of mild/moderate COVID-19 (year) 0.04 [38]
Categories of data Data value Source
 4.3 Disability weight of severe/critical COVID-19 0.53 [20]
 4.4 Duration of severe/critical COVID-19 (year) 0.12 [38]
 4.5 Disability weight of sequela 0.17 [20]
 4.6 Sequelae duration (year) 0.25 [3]

A complete list of all input data with ranges and distributions are reported in Appendix 4.1 in Supplemental Materials found at https://doi.org/10.1016/j.jval.2020.12.009.